Active — Not RecruitingNot Applicable

The Parents in Appalachia Receive Education Needed for Teen Project

United States624 participantsStarted 2012-01

Plain-language summary

This clinical trial studies an educational intervention for parents and providers in increasing human papillomavirus (HPV) vaccination rates in younger girls in Ohio Appalachia. Educational interventions may be effective in increasing the number of participants whose daughters receive HPV vaccination.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * LEVEL 1: Parents * Be able to speak, read, and write English * Has a daughter who receives care from or lives in one of 12 Ohio Appalachia counties * Be a parent or a guardian of a young girl (age 9 to 17 years) who has not received the HPV vaccine (if a parent has more than one daughter, they will be asked questions about their eldest daughter) * Not have a child who has received the HPV vaccine LEVEL 2: Health care providers * Practicing in a participating public health department or provider office in Ohio Appalachia * Personnel involved in the vaccine process (determined by individual health departments or clinic) * Able to speak, read, and write English Exclusion Criteria: LEVEL 1: Parents * Not able to speak, read, and write English * Does not have a daughter who receives care from or lives in one of 12 Ohio Appalachia counties * Not the parent or a guardian of a young girl (age 9 to 17 years) who has not received the HPV vaccine (if a parent has more than one daughter, they will be asked questions about their eldest daughter) * Has a child who has received the HPV vaccine LEVEL 2: Health care providers * Does not practicing in a participating public health department or provider office in Ohio Appalachia * Personnel that is not involved in the vaccine process (determined by individual health departments or clinic) * Not able to speak, read, and write English

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Proportion of daughters of participating parents who received their first HPV vaccination

Timeframe: Within 3 months of viewing educational material

Trial details

NCT IDNCT01901770

SponsorOhio State University Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Healthy trials